Technical Analysis for BPTH - Bio-Path Holdings Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.14 | -8.55% | -0.20 |
BPTH closed down 8.55 percent on Friday, May 17, 2024, on 3 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Jack-in-the-Box Bearish | Bearish Swing Setup | -8.55% | |
| Narrow Range Bar | Range Contraction | -8.55% | |
| Earnings Movers | Other | -8.55% |
| Alert | Time |
|---|---|
| Down 5% | 2 days ago |
| Down 3% | 2 days ago |
| Jack-in-the-Box Bearish Entry | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 2 % | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 44.8 |
| 52 Week Low | 2.0 |
| Average Volume | 1,814,711 |
| 200-Day Moving Average | 7.77 |
| 50-Day Moving Average | 3.60 |
| 20-Day Moving Average | 2.65 |
| 10-Day Moving Average | 2.59 |
| Average True Range | 0.43 |
| RSI (14) | 33.33 |
| ADX | 19.96 |
| +DI | 23.55 |
| -DI | 26.03 |
| Chandelier Exit (Long, 3 ATRs) | 6.38 |
| Chandelier Exit (Short, 3 ATRs) | 3.29 |
| Upper Bollinger Bands | 3.07 |
| Lower Bollinger Band | 2.23 |
| Percent B (%b) | -0.1 |
| BandWidth | 31.91 |
| MACD Line | -0.39 |
| MACD Signal Line | -0.41 |
| MACD Histogram | 0.0185 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.61 | ||||
| Resistance 3 (R3) | 2.61 | 2.46 | 2.53 | ||
| Resistance 2 (R2) | 2.46 | 2.34 | 2.46 | 2.50 | |
| Resistance 1 (R1) | 2.30 | 2.27 | 2.23 | 2.30 | 2.48 |
| Pivot Point | 2.15 | 2.15 | 2.11 | 2.15 | 2.15 |
| Support 1 (S1) | 1.99 | 2.03 | 1.92 | 1.99 | 1.80 |
| Support 2 (S2) | 1.84 | 1.96 | 1.84 | 1.78 | |
| Support 3 (S3) | 1.68 | 1.84 | 1.75 | ||
| Support 4 (S4) | 1.68 |
